Clinical Trial Detail

NCT ID NCT03611556
Title MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors MedImmune LLC
Indications

pancreatic adenocarcinoma

Therapies

Gemcitabine + Nab-paclitaxel + Oleclumab

Durvalumab + Gemcitabine + Nab-paclitaxel + Oleclumab

Fluorouracil + Leucovorin + Oxaliplatin

Fluorouracil + Leucovorin + Oleclumab + Oxaliplatin

Durvalumab + Fluorouracil + Leucovorin + Oleclumab + Oxaliplatin

Age Groups: adult senior

No variant requirements are available.